Do You Know the Latest on Managing Type 2 Diabetes?

Dr Rob Hicks


November 25, 2019

In its management of adults with type 2 diabetes guidance NICE recommends offering standard-release metformin as the initial drug treatment for adults with type 2 diabetes, and minimising the risk of gastrointestinal side effects by gradually increasing the dose over several weeks. If gastrointestinal side effects occur then a trial of modified-release metformin can be considered. NICE advises that should metformin not be tolerated, or is contraindicated, then for adults with type 2 diabetes initial drug treatment with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, or pioglitazone, or a sulfonylurea should be considered.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.